Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

France-Based Unither USA Plans $15.7 Million Expansion At Its Henrietta, New York, Production Hub

08/06/2014
France-based Unither USA, a developer and contract manufacturer of pharmaceuticals, plans to undertake a $15.7 million expansion project at its manufacturing center in Henrietta, New York. The firm produces syrups, capsules and tablet medications in its current facility just outside of Rochester.

The project will include new equipment purchases and build-out of existing space to bring novel single unit dose manufacturing capabilities to the facility, enhancing its competiveness in the pharmaceutical industry.

“Unither’s decision to expand in the Greater Rochester region is a testament to the economic transformation we are helping to bring about in Upstate New York,” Governor Andrew Cuomo said. “Advanced manufacturing offers tremendous opportunities for growth in the region, and by working alongside our local and private sector partners we are attracting new investments and growing the surrounding economy. With that in mind, today’s investment will allow Unither become more competitive, create jobs and continue thriving in the area for years to come, and I am proud that the State was able to move this project forward.”

“Unither is proud to be operating in Upstate New York, where we will offer the improved safety and convenience of single unit dose medications to the largest pharma market in the world,” said Unither’s General Manager for North America, Kevin Haehl. “We want to thank Governor Cuomo and the Finger Lakes Regional Economic Development Council for their steadfast support, trust and assistance as Unither expands our Rochester operation and seeks to establish a competitive North American presence for the first time.”

New York State, through Empire State Development, the state’s economic development agency, will provide up to $542,666 in Excelsior Job Program tax credits in return for Unither’s job creation commitments. Unither is also eligible for New York’s Standard Investment Tax Credit on the capital investment made here which, when combined with the Excelsior award, total more than $1.3 million in fully refundable tax credits. These performance-based incentives will allow Unither to purchase new technology and start its expansion project, bringing new product lines to the facility. To assist with Unither’s expansion, Monroe County is also considering a sales tax exemption on build out costs of $2,865,000.

Unither Manufacturing Rochester Senior Plant Director Dave Hollingshead said, “New York State has spoken loudly with their support for the Unither strategy. We have a highly skilled workforce, great educational institutions, and fantastic partnerships with state and local government in this region. We look forward to leveraging these strengths and building on our 57-year history of manufacturing pharmaceutical products, simplifying the lives of patients, and supporting our most important asset, our employees.”

ESD President, CEO and Commissioner Kenneth Adams said, “Governor Cuomo is helping Upstate New York become a global competitor in pharmaceuticals and manufacturing, thanks to our skilled labor force, academic-industry partnerships and quality of life. Unither’s expansion highlights the Greater Rochester region’s significance in the global economy and adds 22 new jobs while securing 262 positions.”

Exclusive Research